Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $44.3000 (-0.89%) ($41.6000 - $45.0000) on Tue. Jun. 24, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.54% (three month average) | RSI | 46 | Latest Price | $44.3000(-0.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWI(7%) IWM(7%) JNK(7%) PEJ(7%) VT(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.77% in a week (0% probabilities). VIXM(-5%) TLT(-4%) UUP(-2%) GLD(-2%) SLV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.77% (StdDev 5.54%) | Hourly BBV | 0 () | Intraday Trend | 4% | | | |
|
1 - 5 Day Possible Target | $36.57(-17.45%) | Resistance Level | $45.29 | 5 Day Moving Average | $43.62(1.56%) | 10 Day Moving Average | $44.18(0.27%) | 20 Day Moving Average | $45.29(-2.19%) | To recent high | -54.3% | To recent low | 5.2% | Market Cap | $873m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |